I've just listened to the Neil Mitchell interview and I'd respectfully disagree with those posters who have criticised both the delivery and content of the interview by the CEO.
He didn't try to present the product as anything other than what it is, which is (currently) a POC tool to be used by clinicians. No false claims, no bullshit, nothing other than honest answers.
I'd prefer that anyday over someone hired by the company to hype a particular product.
I also thought Neil Mitchell's positive response to the test's multi-functions/uses was instructive.
Good stuff - but obviously at odds with several other posters who's opinion I respect.
Derek on 3AW 7/9/21, page-38
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 360700 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 24 | 1 |
View Market Depth
| Last trade - 10.34am 12/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable